Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXA3E1
|
||||
Drug Name |
SID535898
|
||||
Synonyms |
CHEMBL609013
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C17H14N2O2
|
||||
Canonical SMILES |
Cc1cc2cc3OCOc3cc2c(n1)c4ccc(N)cc4
|
||||
InChI |
InChI=1S/C17H14N2O2/c1-10-6-12-7-15-16(21-9-20-15)8-14(12)17(19-10)11-2-4-13(18)5-3-11/h2-8H,9,18H2,1H3
|
||||
InChIKey |
ZHLRBDNNCVOICW-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Endosomal/Vacuolar pathway | ||||
Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
MHC class II antigen presentation | |||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.